As of Nov 27
| +0.04 / +0.20%|
The 3 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 25.00, with a high estimate of 25.00 and a low estimate of 23.00. The median estimate represents a +24.75% increase from the last price of 20.04.
The current consensus among 3 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.